AVITA Medical Inc

NASDAQ:RCEL   12:52:05 PM EDT
18.21
-0.50 (-2.67%)
Products

FDA Approves Ide Amendment To A Single-Arm Design For Avita Medical’S Pivotal Study Of The Recell® System For Vitiligo Treatment

Published: 08/16/2021 12:22 GMT
(RCEL) - FDA Approves Ide Amendment to a Single-arm Design for Avita Medical’s Pivotal Study of the Recell® System for Vitiligo Treatment.